Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Epigenetics provides new insights into the pathogenesis of lymphoma ... of Cambridge and the University of Southern California (USC), molecular biologist Melanie Hassler from the working group led by Gerda Egger (Department of Pathology at MedUni Vienna, Division of Experimental Pathology, Head: Lukas Kenner) has analysed the methylation pattern of Anaplastic Large Cell... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-october-2016/epigenetics-provides-new-insights-into-the-pathogenesis-of-lymphoma/
Study reveals new therapeutic option for head and neck carcinomas ... leader Lorenz Kadletz-Wanke, summarising the key finding of the research, which was conducted at MedUni Vienna's Department of Otorhinolaryngology and Head and Neck Surgery in collaboration with Lukas Kenner (MedUni Vienna's Department of Pathology, Department of Laboratory Animal Pathology at Vetmeduni Vienna) and Stefan Stoiber (MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy). Service: Pharmaceuticals Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-Wanke L... https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/studie-zeigt-neue-therapieoption-bei-kopf-halstumoren-auf/
Study reveals new therapeutic option for head and neck carcinomas ... leader Lorenz Kadletz-Wanke, summarising the key finding of the research, which was conducted at MedUni Vienna's Department of Otorhinolaryngology and Head and Neck Surgery in collaboration with Lukas Kenner (MedUni Vienna's Department of Pathology, Department of Laboratory Animal Pathology at Vetmeduni Vienna) and Stefan Stoiber (MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy). Service: Pharmaceuticals Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma. Brkic FF, Stoiber S, Maier T, Gurnhofer E, Kenner L, Heiduschka G, Kadletz-Wanke L... https://www.meduniwien.ac.at/web/en/ueber-uns/news/default-0f889c8985-2/studie-zeigt-neue-therapieoption-bei-kopf-halstumoren-auf/medicine-science/
PET imaging and pathology used to create tumour "maps" for precision treatment ... specialist Alexander Haug and pathologist Lukas Kenner. Using Positron Emission Tomography (PET) in conjunction with fine tissue tumour analysis, the aim is to identify the specific metabolic "fingerprint" of relevant genetic changes in the tumour. The pattern that is obtained will act as a tumour "map", so... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/pet-imaging-and-pathology-used-to-create-tumour-maps-for-precision-treatment/university/
PET imaging and pathology used to create tumour "maps" for precision treatment ... specialist Alexander Haug and pathologist Lukas Kenner. Using Positron Emission Tomography (PET) in conjunction with fine tissue tumour analysis, the aim is to identify the specific metabolic "fingerprint" of relevant genetic changes in the tumour. The pattern that is obtained will act as a tumour "map", so... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/pet-imaging-and-pathology-used-to-create-tumour-maps-for-precision-treatment/medicine-science/
PET imaging and pathology used to create tumour "maps" for precision treatment ... specialist Alexander Haug and pathologist Lukas Kenner. Using Positron Emission Tomography (PET) in conjunction with fine tissue tumour analysis, the aim is to identify the specific metabolic "fingerprint" of relevant genetic changes in the tumour. The pattern that is obtained will act as a tumour "map", so... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-jaenner-2019/pet-imaging-and-pathology-used-to-create-tumour-maps-for-precision-treatment/
Monika Oberhuber vom Klinischen Institut für Pathologie der MedUni Wien mit Rokitansky-Preis ausgezeichnet ...Alle News – Medizin & Wissenschaft (Wien, 21-09-2020) Für ihre im Topjournal "Molecular Systems Biology“ publizierte Studie "STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer" wurde Monika Oberhuber nun mit dem Carl von Rokitansky-Preis ausgezeichnet. Mittels bioinformatischer Methoden konnte sie nachweisen, dass die hohe Expression des Gens PDK4 mit einer besseren Prognose bei Prostatakrebs assoziiert ist. Die Publikation entstand am Klinischen Institut für Pathologie der MedUni Wien unter der Leitung von Lukas Kenner im Rahmen eines Projekts des „Center for Biomarker Research in Medicine“ (CBmed GmbH), einem von der Österreichischen Forschungs-Förderungsgesellschaft (FFG) geförderten COMET K1-Zentrum. Der Rokitansky-Preis wird von der Firma Roche gesponsert und von der Österreichischen Gesellschaft für Klinische Pathologie... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-september-2020/monika-oberhuber-vom-klinischen-institut-fuer-pathologie-der-meduni-wien-mit-rokitansky-preis-ausgezeichnet/
Monika Oberhuber vom Klinischen Institut für Pathologie der MedUni Wien mit Rokitansky-Preis ausgezeichnet ...Alle News – Medizin & Wissenschaft (Wien, 21-09-2020) Für ihre im Topjournal "Molecular Systems Biology“ publizierte Studie "STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer" wurde Monika Oberhuber nun mit dem Carl von Rokitansky-Preis ausgezeichnet. Mittels bioinformatischer Methoden konnte sie nachweisen, dass die hohe Expression des Gens PDK4 mit einer besseren Prognose bei Prostatakrebs assoziiert ist. Die Publikation entstand am Klinischen Institut für Pathologie der MedUni Wien unter der Leitung von Lukas Kenner im Rahmen eines Projekts des „Center for Biomarker Research in Medicine“ (CBmed GmbH), einem von der Österreichischen Forschungs-Förderungsgesellschaft (FFG) geförderten COMET K1-Zentrum. Der Rokitansky-Preis wird von der Firma Roche gesponsert und von der Österreichischen Gesellschaft für Klinische Pathologie... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-september-2020/monika-oberhuber-vom-klinischen-institut-fuer-pathologie-der-meduni-wien-mit-rokitansky-preis-ausgezeichnet/medizin-wissenschaft/
Detailsite | MedUni Vienna .... Dr. Lukas Kenner, Medical University of Vienna, has for a while been dealing with highly-malignant lymphomas (malignant tumours of the lymph nodes) which also often occur in children. Typical of lymphomas is the pathological link of chromosomes to combine genes that are otherwise not connected... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/new-therapeutic-approaches-for-lymph-node-cancer/
Promising approach for prognosis and treatment in mastocytosis ... cytokine levels can therefore help to make a more accurate assessment of the individual prognosis in mastocytosis," says Hörmann.Working in collaboration with the working groups of Veronika Sexl of the Institute of Pharmacology and Toxicology of  VetmedUni Vienna and Lukas Kenner (Department of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2016/news-in-december-2016/promising-approach-for-prognosis-and-treatment-in-mastocytosis/